The Functional Stem Cell Marker Aldehyde Dehydrogenase Enhances Pancreatic Cancer Stem Cell Isolation And Correlates With Clinical Prognosis

Researchers have identified aldehyde dehydrogenase as a new marker for the presence of pancreatic cancer stem cells, a finding with potential for the development of targeted therapy. Pancreatic cancer is highly aggressive and largely resistant to current therapies. Researchers believe that pancreatic cancer stem cells may be responsible for resistance to chemotherapy.

More: continued here

Filed under: Cancer on April 17th, 2008